Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life CyclePaola Favuzza, Alan F. Cowman, Julie Healer et al.|Cell Host & Microbe|2020Cited by 167
Development of a liver-targeted siRNA delivery platform with a broad therapeutic window utilizing biodegradable polypeptide-based polymer conjugatesStephanie E. Barrett, Steven L. Colletti, Rob S. Burke et al.|Journal of Controlled Release|2014Cited by 31
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of MalariaManuel de Lera Ruiz, John A. McCauley, Paola Favuzza et al.|ACS Medicinal Chemistry Letters|2022Cited by 26
MK-7602: a potent multi-stage dual-targeting antimalarialPaola Favuzza, Alan F. Cowman, Josephine Palandri et al.|EBioMedicine|2025Cited by 6